RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia

10.1038/s41388-020-01567-7

Saved in:

Bibliographic Details
Main Authors:	Koschut, David, Ray, Debleena, Li, Zhenhua, Giarin, Emanuela, Groet, Jurgen, Alic, Ivan, Kham, Shirley Kow-Yin, Chng, Wee Joo, Ariffin, Hany, Weinstock, David M, Yeoh, Allen Eng-Juh, Basso, Giuseppe, Nizetic, Dean
Other Authors:	DEAN'S OFFICE (MEDICINE)
Format:	Article
Language:	English
Published:	SPRINGERNATURE 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Oncology Cell Biology Genetics & Heredity
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/228999
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-228999
record_format	dspace
spelling	sg-nus-scholar.10635-2289992024-11-09T05:58:51Z RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia Koschut, David Ray, Debleena Li, Zhenhua Giarin, Emanuela Groet, Jurgen Alic, Ivan Kham, Shirley Kow-Yin Chng, Wee Joo Ariffin, Hany Weinstock, David M Yeoh, Allen Eng-Juh Basso, Giuseppe Nizetic, Dean DEAN'S OFFICE (MEDICINE) PAEDIATRICS Prof Wee Joo Chng Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Oncology Cell Biology Genetics & Heredity 10.1038/s41388-020-01567-7 ONCOGENE 40 4 746-762 2022-07-21T05:20:44Z 2022-07-21T05:20:44Z 2021-01-28 2022-07-17T12:07:07Z Article Koschut, David, Ray, Debleena, Li, Zhenhua, Giarin, Emanuela, Groet, Jurgen, Alic, Ivan, Kham, Shirley Kow-Yin, Chng, Wee Joo, Ariffin, Hany, Weinstock, David M, Yeoh, Allen Eng-Juh, Basso, Giuseppe, Nizetic, Dean (2021-01-28). RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia. ONCOGENE 40 (4) : 746-762. ScholarBank@NUS Repository. https://doi.org/10.1038/s41388-020-01567-7 09509232 1476-5594 https://scholarbank.nus.edu.sg/handle/10635/228999 en SPRINGERNATURE Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Oncology Cell Biology Genetics & Heredity
spellingShingle	Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Oncology Cell Biology Genetics & Heredity Koschut, David Ray, Debleena Li, Zhenhua Giarin, Emanuela Groet, Jurgen Alic, Ivan Kham, Shirley Kow-Yin Chng, Wee Joo Ariffin, Hany Weinstock, David M Yeoh, Allen Eng-Juh Basso, Giuseppe Nizetic, Dean RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
description	10.1038/s41388-020-01567-7
author2	DEAN'S OFFICE (MEDICINE)
author_facet	DEAN'S OFFICE (MEDICINE) Koschut, David Ray, Debleena Li, Zhenhua Giarin, Emanuela Groet, Jurgen Alic, Ivan Kham, Shirley Kow-Yin Chng, Wee Joo Ariffin, Hany Weinstock, David M Yeoh, Allen Eng-Juh Basso, Giuseppe Nizetic, Dean
format	Article
author	Koschut, David Ray, Debleena Li, Zhenhua Giarin, Emanuela Groet, Jurgen Alic, Ivan Kham, Shirley Kow-Yin Chng, Wee Joo Ariffin, Hany Weinstock, David M Yeoh, Allen Eng-Juh Basso, Giuseppe Nizetic, Dean
author_sort	Koschut, David
title	RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
title_short	RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
title_full	RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
title_fullStr	RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
title_full_unstemmed	RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
title_sort	ras-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
publisher	SPRINGERNATURE
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/228999
_version_	1821183627462967296

RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia

Similar Items